TGVNX | VMVAX | TGVNX / VMVAX | |
Total Expense Ratio | 0.95 | 0.07 | 1,357% |
Annual Report Gross Expense Ratio | 1.39 | 0.07 | 1,986% |
Fund Existence | 25 years | 14 years | - |
Gain YTD | -2.824 | -1.539 | 183% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 89M | 29.1B | 0% |
Annual Yield % from dividends | 0.99 | 2.40 | 41% |
Returns for 1 year | -4.07 | 3.63 | -112% |
Returns for 3 years | 18.92 | 15.72 | 120% |
Returns for 5 years | 73.96 | 76.66 | 96% |
Returns for 10 years | 13.05 | 75.91 | 17% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JEVNX | 9.16 | 0.03 | +0.33% |
JHancock Disciplined Value Em Mkts EqNAV | |||
GSVTX | 15.54 | 0.02 | +0.13% |
Goldman Sachs Large Cap Value Inv | |||
PTTEX | 68.24 | 0.07 | +0.10% |
Putnam Global Technology R6 | |||
RUBCHF | 0.01 | 0.00 | +0.04% |
Russia Ruble - Switzerland Franc | |||
HKDNZD | 0.22 | N/A | N/A |
Hong Kong Dollar - New Zealand Dollar |